During the past decade, AdventHealth Orlando conducted 294 clinical trials. In the 10-year time frame, 294 clinical trials started and 234 clinical trials were completed, i.e. on average, 79.6% percent of trials that started reached the finish line to date. In the past 5 years, 106 clinical trials started and 97 clinical trials were completed. i.e. 91.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "AdventHealth Orlando" #1 sponsor was "National Cancer Institute (NCI)" with 123 trials, followed by "Children's Oncology Group" with 66 trials sponsored, "AdventHealth" with 44 trials sponsored, "Boston Scientific Corporation" with 26 trials sponsored and "Abbott Medical Devices" with 26 trials sponsored. Other sponsors include 315 different institutions and companies that sponsored additional 177 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "AdventHealth Orlando" #1 collaborator was "National Cancer Institute (NCI)" with 129 trials as a collaborator, "NRG Oncology" with 33 trials as a collaborator, "Canadian Cancer Trials Group" with 7 trials as a collaborator, "AdventHealth" with 6 trials as a collaborator and "NCIC Clinical Trials Group" with 6 trials as a collaborator. Other collaborators include 243 different institutions and companies that were collaborators in the rest 181 trials.

According to Clinical.Site data, the most researched conditions in "AdventHealth Orlando" are "Coronary Artery Disease" (27 trials), "Recurrent Neuroblastoma" (21 trials), "Heart Failure" (19 trials), "Recurrent Osteosarcoma" (17 trials) and "Atrial Fibrillation" (16 trials). Many other conditions were trialed in "AdventHealth Orlando" in a lesser frequency.

Most popular intervention types in "AdventHealth Orlando" are "Drug" (357 trials), "Other" (220 trials), "Device" (148 trials), "Biological" (109 trials) and "Procedure" (93 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (118 trials), "Quality-of-Life Assessment" (56 trials), "Placebo" (44 trials), "Cyclophosphamide" (43 trials) and "Carboplatin" (40 trials). Other intervention names were less common.

The vast majority of trials in "AdventHealth Orlando" are 530 trials for "All" genders, 65 trials for "Female" genders and 9 trials for "Male" genders.

Currently, there are NaN active trials in "AdventHealth Orlando". undefined are not yet recruiting, 114 are recruiting, 171 are Active, not recruiting, and 3 are Enrolling by invitation. In total, there were 242 completed trials in AdventHealth Orlando, 5 suspended trials, and 44 terminated clinical trials to date.

Out of the total trials that were conducted in AdventHealth Orlando, 25 "Phase 1" clinical trials were conducted, 160 "Phase 2" clinical trials and 235 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 18 trials, and there were also 110 trials that are defined as “Not Applicable".

AdventHealth Orlando has several departments that took part in Clinical trials: "Florida Hospital Cancer Institute at Florida Hospital Orlando" - 58 trials, "AdventHealth Medical Group Urology at Orlando" - 24 trials, "Munroe Regional Medical Center" - 24 trials, "Florida Hospital Pepin Heart Institute" - 22 trials, "AMITA Health Cancer Institute and Outpatient Center" - 17 trials, "Kansas City Cancer Center-Shawnee Mission" - 13 trials, "Lake Mary Pediatrics" - 8 trials, "Cancer Center of Kansas - Ottawa" - 7 trials, "Florida Hospital Cardiovascular Institute" - 5 trials, "AdventHealth Hematology and Oncology" - 5 trials, "The Center for Cardiovascular Studies Kramer & Crouse Cardiology" - 4 trials, "Florida Hospital Orthopaedic Institute and Fracture Care Center" - 2 trials, "AdventHealth Diabetes Institute" - 2 trials